Meyka AI API is live for developers.Start building.
Advertisement
Canna-Global Acquisition Corp

CNGLW News Today: Stay Updated with the Latest Canna-Global Acquisition Corp News in Real Time

Find CNGLW news now at Meyka AI. Stay informed with the latest{" "} Canna-Global Acquisition Corp stocks updates, including price news, market analysis, and expert insights.

CNGLWNASDAQ
Financial ServicesShell Companies
$0.00
$0.009(98.90%)
U.S. Market opens in 62h 10m
Advertisement
PayPay Stock Falls 10.6% on T&D Insurance Acquisition Deal, June 06
📅 1 hour ago

PayPay Stock Falls 10.6% on T&D Insurance Acquisition Deal, June 06

PayPay acquires 70.2% stake in T&D Financial Life Insurance, expanding into life insurance with SoftBank’s AI technology backing.

Read more 12
AMD Stock Surges in Focus After 12,941% Gain Since 2016 – But 204x P/E Raises Risk 
📅 9 hours ago

AMD Stock Surges in Focus After 12,941% Gain Since 2016 – But 204x P/E Raises Risk 

Advanced Micro Devices (AMD) has been one of the stock market’s biggest success stories, delivering a staggering 12,941% gain since 2016. The chipmaker transformed itself from a struggling semiconductor company into a major player in artificial intelligence and data centers.  As of June 2026, investors remain bullish on AMD’s growth potential, but its lofty valuation…

Read more 12
Broadcom Inc. (AVGO) Stock Analysis: Decoding Premium Valuation in the AI Hyper-Growth Era
📅 11 hours ago

Broadcom Inc. (AVGO) Stock Analysis: Decoding Premium Valuation in the AI Hyper-Growth Era

Broadcom Inc. has become one of the biggest winners of the artificial intelligence boom. In fiscal 2026, the company continued reporting strong AI-driven growth, with demand for custom chips and networking solutions rising across major cloud providers.  As of June 2026, investors remain focused on whether AVGO’s soaring share price and premium valuation can be…

Read more 12
Wealthsimple Opens IPO Access to Retail Investors, SpaceX Joins June 04
📅 18 hours ago

Wealthsimple Opens IPO Access to Retail Investors, SpaceX Joins June 04

Wealthsimple IPO Access lets Canadian retail investors request shares in select IPOs at offering price with no minimum order or fees.

Read more 12
Rajesh Exports Hits Lower Circuit as SEBI Alleges ₹15.15 Lakh Crore Fraud, June 04
📅 1 day ago

Rajesh Exports Hits Lower Circuit as SEBI Alleges ₹15.15 Lakh Crore Fraud, June 04

SEBI alleges Rajesh Exports inflated revenues by ₹15.15 lakh crore between FY21-FY25. Stock hits 5% lower circuit. Promoter barred from trading.

Read more 12
Morrisons to Close 100 Stores as Costs Soar, June 04
📅 1 day ago

Morrisons to Close 100 Stores as Costs Soar, June 04

Morrisons to close 100 Daily convenience stores in 2026 due to losses and rising government policy costs. First seven closures confirmed.

Read more 12
NVIDIA Corp Stock Update: NVDA Falls 0.69% to $222.82 After RTX Spark News
📅 2 days ago

NVIDIA Corp Stock Update: NVDA Falls 0.69% to $222.82 After RTX Spark News

NVIDIA Corp (NVDA) shares slipped 0.69% to $222.82 following the company’s latest RTX Spark announcement in early June 2026. The new AI-focused platform highlights NVIDIA’s growing ambitions beyond traditional graphics processing and deeper into next-generation personal computing.  Yet the market response was cautious. Why did investors react this way despite a major product unveiling? The…

Read more 12
SpaceX Seeks $75 Billion IPO Valuation With 555.6 Million Shares
📅 3 days ago

SpaceX Seeks $75 Billion IPO Valuation With 555.6 Million Shares

SpaceX is preparing for what could become the largest initial public offering in market history. The Elon Musk-led space and satellite company is reportedly seeking to raise $75 billion by selling 555.6 million shares at a target price of $135 per share. The proposed deal values SpaceX at approximately $1.75 trillion, placing it among the…

Read more 12
Apotex Health Plans $1B IPO on TSX, Valuing Generic Drugmaker at $5B
📅 3 days ago

Apotex Health Plans $1B IPO on TSX, Valuing Generic Drugmaker at $5B

Apotex Health launches $1B IPO on TSX, valuing the generic drugmaker at $5B. The company plans to sell 41.7-50M shares at C$20-C$24 per share.

Read more 12

CNGLW News FAQ